HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congress Presses FDA To Speak Up On OTC/Supplement Combo Products

This article was originally published in The Tan Sheet

Executive Summary

Congressional interest turns up the pressure on FDA to make a statement on Bayer Aspirin with Heart Advantage, and issue a definitive policy on any products that combine dietary supplement and OTC drug ingredients

You may also be interested in...



Bayer Reboots Heart Advantage With Promotion For Aspirin

Bayer is using the reformulation of its Bayer Heart Health Advantage cholesterol-lowering phytosterol supplement as an opportunity to cross-promote with its aspirin brand

Sea Changes In Regulation And The Market: Top Stories Of 2008

When an iconic drug brand drew scrutiny on Capitol Hill for possibly violating FDA's policy against combinations of drugs and dietary supplements, OTC and supplement interests took notice

FDA Commissioner Must Not Come From Agency, Stupak Advises Obama

Rep. Bart Stupak has called on the incoming administration to look outside FDA for the next commissioner - even to fill the post short-term on an acting basis

Related Content

Topics

UsernamePublicRestriction

Register

RS137217

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel